0

Red Cell Disorders Collection
 1-20 of 511 Articles
Reviews |  3 December 2013 FREE
Treatment of Anemia in Patients With Heart Disease: A Systematic Review
Devan Kansagara, MD, MCR; Edward Dyer, MD; Honora Englander, MD; et al.
Ann Intern Med. 2013;159(11):746-757. doi:10.7326/0003-4819-159-11-201312030-00007
Clinical Guidelines |  3 December 2013 FREE
Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem, MD, PhD, MHA; Linda L. Humphrey, MD, MPH; Nick Fitterman, MD; et al.
Ann Intern Med. 2013;159(11):770-779. doi:10.7326/0003-4819-159-11-201312030-00009
Ideas and Opinions |  5 November 2013
Emphasis and Priority
G. Stuart Mendenhall, MD
Ann Intern Med. 2013;159(9):627-628. doi:10.7326/0003-4819-159-9-201311050-00009
Letters |  2 July 2013
Successful Treatment of the Postpartum Atypical Hemolytic Uremic Syndrome With Eculizumab
Stefan Zschiedrich, MD; Eric P. Prager, MD; E. Wolfgang Kuehn, MD
Ann Intern Med. 2013;159(1):76. doi:10.7326/0003-4819-159-1-201307020-00023
Editorials |  6 July 2010 FREE
Anemia Management in Chronic Kidney Disease: Bursting the Hemoglobin Bubble
Daniel E. Weiner, MD, MS; Dana C. Miskulin, MD, MS
Ann Intern Med. 2010;153(1):53-55. doi:10.7326/0003-4819-153-1-201007060-00250
Reviews |  15 April 2008
Narrative Review: Paroxysmal Nocturnal Hemoglobinuria: The Physiology of Complement-Related Hemolytic Anemia
Robert A. Brodsky, MD
Ann Intern Med. 2008;148(8):587-595. doi:10.7326/0003-4819-148-8-200804150-00003
Articles |  15 January 2008
Daily Assessment of Pain in Adults with Sickle Cell Disease
Wally R. Smith, MD; Lynne T. Penberthy, MD, MPH; Viktor E. Bovbjerg, PhD, MPH; et al.
Ann Intern Med. 2008;148(2):94-101. doi:10.7326/0003-4819-148-2-200801150-00004
Articles |  7 February 2006 FREE
Brief Communication: Successful Treatment of Pure Red-Cell Aplasia with an Anti–Interleukin-2 Receptor Antibody (Daclizumab)
Elaine M. Sloand, MD; Phillip Scheinberg, MD; Jaroslaw Maciejewski, MD; et al.
Ann Intern Med. 2006;144(3):181-185. doi:10.7326/0003-4819-144-3-200602070-00006
Articles |  16 September 2003
The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis
Marco Ruggeri, MD; Alberto Tosetto, MD; Maurizio Frezzato, MD; et al.
Ann Intern Med. 2003;139(6):470-475. doi:10.7326/0003-4819-139-6-200309160-00009
Ideas and Opinions |  1 April 2003
Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?[dhelix]
Richard S. Cooper, MD; Bruce M. Psaty, MD, PhD
Ann Intern Med. 2003;138(7):576-580. doi:10.7326/0003-4819-138-7-200304010-00014
Supplement: The Future of Primary Care |  4 February 2003
Primary Care at a Crossroads
Jonathan Showstack, PhD, MPH; Arlyss Anderson Rothman, PhD, MHS, FNP; Susan Hassmiller, PhD, RN
Ann Intern Med. 2003;138(3):242-243. doi:10.7326/0003-4819-138-3-200302040-00031
Articles |  6 August 2002
Outcome of Pregnancy and Disease Course among Women with Aplastic Anemia Treated with Immunosuppression
André Tichelli, MD; Gérard Socié, MD, PhD; Judith Marsh, MD; et al.
Ann Intern Med. 2002;137(3):164-172. doi:10.7326/0003-4819-137-3-200208060-00008
Brief Communications |  7 May 2002
Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation
Pietro Muretto, MD; Emanuele Angelucci, MD; Guido Lucarelli, MD
Ann Intern Med. 2002;136(9):667-672. doi:10.7326/0003-4819-136-9-200205070-00009
Brief Communications |  18 December 2001
Quinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term Outcomes
Kiarash Kojouri, MD, MPH; Sara K. Vesely, PhD; James N. George, MD
Ann Intern Med. 2001;135(12):1047-1051. doi:10.7326/0003-4819-135-12-200112180-00008
Articles |  6 November 2001 FREE
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
Brian J. McMahon, MD; Peter Holck, PhD; Lisa Bulkow, MS; et al.
Ann Intern Med. 2001;135(9):759-768. doi:10.7326/0003-4819-135-9-200111060-00006
Articles |  2 October 2001
Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic Anemia
Robert A. Brodsky, MD; Lyle L. Sensenbrenner, MD; B. Douglas Smith, MD; et al.
Ann Intern Med. 2001;135(7):477-483. doi:10.7326/0003-4819-135-7-200110020-00006
Editorials |  2 October 2001
Aplastic Anemia: Which Treatment?
Janis L. Abkowitz, MD
Ann Intern Med. 2001;135(7):524-526. doi:10.7326/0003-4819-135-7-200110020-00012
Brief Communications |  17 April 2001
Neocytolysis on Descent from Altitude: A Newly Recognized Mechanism for the Control of Red Cell Mass
Lawrence Rice, MD; Wilson Ruiz, MD; Theda Driscoll, CNT; et al.
Ann Intern Med. 2001;134(8):652-656. doi:10.7326/0003-4819-134-8-200104170-00010
Editorials |  17 April 2001
Out of Thin Air: The Evolving Enigma of Erythropoietin and Neocytolysis
Bernard A. Harris, MD; Paul E. Epstein, MD
Ann Intern Med. 2001;134(8):710-712. doi:10.7326/0003-4819-134-8-200104170-00015
Articles |  5 September 2000
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
Ernest Beutler, MD; Vincent Felitti, MD; Terri Gelbart, BS; et al.
Ann Intern Med. 2000;133(5):329-337. doi:10.7326/0003-4819-133-5-200009050-00008
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)